If you’re like me you’ve spent the last several weeks so enmeshed in the day-to-day negotiations around Democrats’ signature drug pricing bill that you haven’t had the time to take a breath and actually think about what this package of policies actually means for the health care industry. Now that the House has passed their bill and has taken off for the Thanksgiving holiday, I figure it’s time to do just that. Here are a few of my biggest questions about the Build Back Better Act.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,